Meningococcal vaccine evolution
Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease....
Main Authors: | Gianni Bona, Carla Guidi |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd
2012-06-01
|
Series: | Clinical Management Issues |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/627 |
Similar Items
-
Las vacunas conjugadas contra la enfermedad meningococica causadas por los serogrupos A, C, W-135, Y
by: Marcos Aurelio P. Sáfadi
Published: (2009-08-01) -
Vacinas meningocócicas conjugadas: eficácia e novas combinações Meningococcal conjugate vaccines: efficacy and new combinations
by: Marco Aurélio Palazzi Sáfadi, et al.
Published: (2006-07-01) -
Vaccines against Meningococcal Diseases
by: Mariagrazia Pizza, et al.
Published: (2020-10-01) -
Herd Protection against Meningococcal Disease through Vaccination
by: Stephen A. Clark, et al.
Published: (2020-10-01) -
Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
by: Hoan Jong Lee, et al.
Published: (2014-11-01)